Sector PE Trend, Return On Asset, and Consensus Earnings Forecast for Facebook, Ford Motor, Ariad Pharmaceuticals, Rite Aid, Sirius XM, and Tesla Motors
HONG KONG, Dec. 20, 2013 /PRNewswire/ -- EarningForecast.com has issued earnings forecast research with special focus on financial performance of the following stocks: Facebook (NASDAQ: FB), Ford Motor (NYSE: F), Ariad Pharmaceuticals (NASDAQ: ARIA), Rite Aid (NYSE: RAD), Sirius XM (NASDAQ: SIRI), and Tesla Motors (NASDAQ: TSLA).
(Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)
Facebook Inc. (NASDAQ: FB): By the end of trading session, Facebook (NASDAQ: FB) shares lost 0.94% to US$55.05 with more than 89.82 million shares traded, compared to its average volume of 64.04 million shares. Within the same day, the industry of Internet Information Providers rose 0.98%. Its rival Twitter, Inc. (TWTR) rose about 3.57%, which brought almost 38% gains to its shareholders during the last 30 days. For the current quarter, Facebook's average estimated revenue is about US$2.33 billion, compared to next quarter's US$2.13 billion. Observing comprehensive analysis of Facebook could help investors have huge gains in investment. Check FB earnings forecast report below.
Read Full Report: http://www.earningforecast.com/PR/122013A/FB/Facebook.pdf
Ford Motor Company (NYSE: F): Ford Motor (NYSE: F) shares began the trading session with a price of US$15.46. When day-trade ended, the stock finally dropped 2.24% (or US$0.35) to US$15.30. The stock traded 84.66 million shares in the last trading session, compared to its daily average of 41.48 million shares. Compared to the industry of Auto Manufacturers which lost 0.39%, General Motors Company (GM) lost 2.35% while it reached a historical high of US$41.85 on Tuesday. Investors may want to find out where Ford Motor will go from here. Observe comprehensive F earnings forecast report here.
Read Full Report: http://www.earningforecast.com/PR/122013A/F/FordMotor.pdf
Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA): The share of Ariad Pharmaceuticals (NASDAQ: ARIA) began the trading session with a price of US$4.98. When day-trade ended, the stock price soared 10.84% to US$5.52 by the end of last trading session. The stock traded 66.47 million shares in the last trading session, compared to its daily average of 21.79 million shares. The index of Biotechnology climbed slightly for about 1.12%. Its competitor Pfizer Inc. (PFE) reached its 52-week high of US$32.50 last month and slid to the last closing price of US$30.71. Do you think Ariad Pharmaceuticals will go on? Do you think now is a good time to buy the stock? Investors could check ARIA earnings forecast report here.
Read Full Report: http://www.earningforecast.com/PR/122013A/ARIA/AriadPharmaceuticals.pdf
Today EarningForecast.com also observed abnormal trade volume for the following companies; Check out the consensus earnings forecast reports below:
Rite Aid Corporation (NYSE: RAD):
Read Full Report: http://www.earningforecast.com/PR/122013A/RAD/RiteAid.pdf
Sirius XM Holdings Inc. (NASDAQ: SIRI):
Read Full Report: http://www.earningforecast.com/PR/122013A/SIRI/SiriusXM.pdf
Tesla Motors Inc. (NASDAQ: TSLA):
Read Full Report: http://www.earningforecast.com/PR/122013A/TSLA/TeslaMotors.pdf
EarningForecast.com focuses on tracking and monitoring company Earnings Data for top market movers in US stocks market. EarningForecast.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.
Please visit: EarningForecast.com/disclaimers/index.php for details.